(1 - 10 von 17
)
Alliance Aims to Accelerate Academic Drug Discovery | GEN - Genetic...
www.genengnews.com
research efforts if needed,” Patrick Chaltin, Ph.D., managing director of The
Centre ...
CD3 and VIB speed up in research for biomarker-defined ...
www.health-house.be
Patrick Chaltin, Managing Director of CD3 at KU Leuven added: "This agreement demonstrates CD3's strong drive to translate promising scientific insights ... › news
KU Leuven launches €60 million fund for innovative biomedical...
sciencebusiness.net
KU Leuven’s Centre for Drug Design and Discovery closes €60 million fund to turn academic research into new medicines
KU Leuven researchers develop an ultrapotent inhibitor of ...
www.news-medical.net
— Patrick Chaltin: "In the future, we want to develop a range of antiviral molecules against the different virus families with pandemic potential, ... › news
sortiert nach Relevanz / Datum